Targeting PD-1/PD-L1 interactions for cancer immunotherapy

被引：296
|
作者：
Zitvogel, Laurence [1 ,2 ,3 ,4 ]
Kroemer, Guido [3 ,5 ,6 ,7 ,8 ]
机构：
[1] Inst Gustave Roussy, INSERM, U1015, F-94805 Villejuif, France
[2] Inst Gustave Roussy, Ctr Clin Invest CBT507, Villejuif, France
[3] Inst Gustave Roussy, Villejuif, France
[4] Univ Paris 11, Villejuif, France
[5] INSERM, U848, Villejuif, France
[6] Ctr Rech Cordeliers, Paris, France
[7] Hop Europeen Georges Pompidou, Paris, France
[8] Univ Paris 05, Fac Med, Paris, France
来源：
ONCOIMMUNOLOGY | 2012年 / 1卷 / 08期
关键词：
CELL CARCINOMA PATIENTS; CLINICAL-SIGNIFICANCE; PD-1; PATHWAY; B7-H1; EXPRESSION; MOLECULE; IMMUNOSUPPRESSION; RECEPTORS; LIGAND-1; ANTIBODY;
D O I：
10.4161/onci.21335
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1223 / 1225
页数：3
相关论文
共 50 条
  • [11] Identifying Rational Candidates for Immunotherapy Targeting PD-1/PD-L1 in Cervical Cancer
    Kim, Miseon
    Kim, Hyojin
    Suh, Dong Hoon
    Kim, Kidong
    Kim, Haeryoung
    Kim, Yong Beom
    No, Jae Hong
    ANTICANCER RESEARCH, 2017, 37 (09) : 5087 - 5094
  • [12] PD-1 Targeting in Cancer Immunotherapy
    Ferris, Robert
    CANCER, 2013, 119 (23) : E1 - E3
  • [13] PD-L1 expression and PD-1/PD-L1 inhibitors in breast cancer
    Monneur, Audrey
    Goncalves, Anthony
    Bertucci, Francois
    BULLETIN DU CANCER, 2018, 105 (03) : 261 - 272
  • [14] Immunotherapy in Breast Cancer: the Emerging Role of PD-1 and PD-L1
    François Bertucci
    Anthony Gonçalves
    Current Oncology Reports, 2017, 19
  • [15] Immunotherapy in Ovarian Cancer: Thinking Beyond PD-1/PD-L1
    Chardin, Laure
    Leary, Alexandra
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [16] The roles of PD-1/PD-L1 in the prognosis and immunotherapy of prostate cancer
    Xu, Yichi
    Song, Gendi
    Xie, Shangdan
    Jiang, Wenxiao
    Chen, Xin
    Chu, Man
    Hu, Xiaoli
    Wang, Zhi-Wei
    MOLECULAR THERAPY, 2021, 29 (06) : 1958 - 1969
  • [17] PD-L1 methylation restricts PD-L1/PD-1 interactions to control cancer immune surveillance
    Huang, Changsheng
    Ren, Shengxiang
    Chen, Yaqi
    Liu, Anyi
    Wu, Qi
    Jiang, Tao
    Lv, Panjing
    Song, Da
    Hu, Fuqing
    Lan, Jingqing
    Sun, Li
    Zheng, Xue
    Luo, Xuelai
    Chu, Qian
    Jia, Keyi
    Li, Yan
    Wang, Jun
    Zou, Caicun
    Hu, Junbo
    Wang, Guihua
    SCIENCE ADVANCES, 2023, 9 (21)
  • [18] Immunotherapy targeting PD-1/PD-L1: A potential approach for the treatment of cancer bone metastases (Review)
    Hiraga, Toru
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2024, 64 (04)
  • [19] In vitro Interactions of Chicken Programmed Cell Death 1 (PD-1) and PD-1 Ligand-1 (PD-L1)
    Reddy, Vishwanatha R. A. P.
    Mwangi, William
    Sadigh, Yashar
    Nair, Venugopal
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2019, 9
  • [20] Targeting Tim-3 in Cancer With Resistance to PD-1/PD-L1 Blockade
    Tian, Tian
    Li, Zhaoming
    FRONTIERS IN ONCOLOGY, 2021, 11
12345